Clene Inc.
CLNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822791
No open-market purchases or sales by Clene Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $19.6M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Clene Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 20 | 27 | +7 |
| Shares | 1.02M | 491.4K | −524.1K (−51.6%) |
| Value | $4.66M | $2.60M | −$2.06M (−44.2%) |
New holders (10)
Institutions that held Clene Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Parsons Capital Management Inc | 36,500 | $193.8K | 0.01% |
| Citadel Advisors LLC | 20,835 | $110.6K | 0.00% |
| Renaissance Technologies LLC | 18,040 | $95.8K | 0.00% |
| SBI Securities Co., Ltd. | 13,025 | $69.2K | 0.00% |
| State Street Corp | 12,501 | $66.4K | 0.00% |
| Fullcircle Wealth LLC | 13,023 | $59.4K | 0.02% |
| Group One Trading, L.P. | 2,333 | $12.4K | 0.00% |
| Washington Trust Co | 150 | $797 | 0.00% |
| MAI Capital Management | 100 | $531 | 0.00% |
| Citigroup Inc | 1 | $5 | 0.00% |
Sold out (3)
Institutions that held Clene Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Armistice Capital, LLC | 682,374 | $3.13M |
| Partnership Wealth Management, LLC | 1,875 | $8.61K |
| JPMorgan Chase & Co | 8 | $37 |